한글목차

소동물 이미징(In-Vivo) 세계 시장 규모는 2030년까지 48억 달러에 달할 것으로 전망

2023년 29억 달러로 추정되는 소동물 이미징(In-Vivo) 세계 시장은 2023-2030년간 연평균 7.7%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 48억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 마이크로 자기공명영상은 8.9%의 연평균 복합 성장률(CAGR)을 기록하여 분석 기간 종료 시점에 11억 달러에 도달할 것으로 예상됩니다. 광학 이미징 분야의 성장률은 분석 기간 동안 CAGR 7.2%로 추정됩니다.

미국 시장은 7억 9,370만 달러로 추정, 중국은 CAGR 7.0%로 성장 전망

미국의 소동물 이미징(In-Vivo) 시장은 2023년 7억 9,370만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 CAGR 7.0%를 기록하며 2030년까지 7억 3,520만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 7.3%와 6.2%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 6.1%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 소동물 이미징(In-Vivo) 시장 - 주요 동향 및 촉진요인 요약

소동물 이미징이 전임상시험에 필수적인 이유는 무엇인가?

소동물 이미징(in vivo)은 살아있는 동물의 생물학적 과정을 모니터링할 수 있는 비침습적이고 고해상도 이미징 솔루션을 제공하기 때문에 전임상시험에 매우 중요합니다. 이 기술은 질병 진행, 치료 효과 및 약동학을 평가하기 위해 의약품 개발, 암 연구, 순환기 연구 및 신경과학에서 널리 사용되고 있습니다. 자기공명영상(MRI), 양전자방출단층촬영(PET), 단일광자방출전산화단층촬영(SPECT), 컴퓨터단층촬영(CT)과 같은 소동물 이미징 기술은 실시간, 종단적, 정량적 데이터를 제공하여 전임상 연구의 신뢰성과 번역적 가치를 높입니다. 맞춤의료, 표적치료, 분자 이미징에 대한 관심이 높아지면서 연구기관, 제약회사, 학술 연구소에서 소동물 이미징 시스템 채택을 촉진하고 있습니다.

기술의 발전은 어떻게 소동물 이미징을 향상시키고 있는가?

기술의 발전은 생물학적 과정에 대한 종합적인 통찰력을 제공하는 멀티모달, 하이브리드, AI 기반 이미징 시스템을 통합하여 소동물 이미징을 향상시키고 있으며, MRI, PET, PET, SPECT, CT를 결합한 멀티모달 이미징 시스템의 연구 개발로 연구자들은 여러 데이터 포인트를 동시에 얻을 수 있게 되었습니다. AI 기반 영상 분석, 딥러닝 알고리즘, 데이터 관리 시스템의 혁신으로 영상 데이터의 자동화, 고처리량화, 정량적 분석이 용이해짐에 따라 연구자들이 여러 데이터 포인트를 동시에 획득할 수 있게 되어 전임상 연구의 정확성과 깊이가 향상되고 있습니다. 정량적 분석이 용이해져 전임상 워크플로우의 시간과 복잡성을 줄일 수 있습니다. 또한, 휴대가 간편하고 컴팩트하며 사용하기 쉬운 이미징 시스템의 출현으로 중소규모의 연구실에서도 고급 이미징 기술에 대한 접근성이 확대되어 공동 연구와 지식 공유가 강화되고 있습니다.

소동물 이미징 시장을 주도하는 시장 세분화는?

이미징 양식에는 마이크로 MRI, PET, SPECT, CT, 광 이미징(생물 발광 및 형광), 초음파가 포함되며, 광 이미징과 PET는 높은 민감도, 특이성 및 실시간 이미징 기능으로 시장을 선도하고 있습니다. 이용 사례는 종양학, 신경학, 순환기학, 감염학, 면역학 등이며, 그 중 종양학은 암 연구와 의약품 개발 연구가 활발히 진행되고 있어 가장 큰 분야로 꼽힙니다. 최종 사용자에는 학술/연구기관, 제약/바이오텍 기업, CRO(임상시험수탁기관) 등이 포함되며, 학술/연구기관은 기초연구와 중개연구에 중점을 두고 있기 때문에 1차 연구기관으로 분류됩니다. 지리적으로는 북미와 유럽이 첨단 연구 인프라를 바탕으로 소동물용 이미징의 최대 시장인 반면, 아시아태평양은 생명과학에 대한 투자 증가, 연구개발 활동 확대, 정밀의료에 대한 관심 증가로 인해 고성장 지역으로 부상하고 있습니다.

소동물 이미징 시장의 성장 촉진요인은?

소동물 이미징 시장의 성장은 전임상 연구 및 의약품 개발에 대한 수요 증가, 멀티모달, 하이브리드, AI 기반 이미징 시스템의 채택 확대, 비침습적 고해상도 이미징 기술의 발전 등 여러 요인에 의해 주도되고 있습니다. 휴대가 간편하고 사용하기 쉬운 소형 이미징 시스템 시장 개척은 학술 연구 기관, 제약사 및 CRO 시장 도입을 촉진하고 있습니다. 고감도, 고특이성, 실시간 이미징 양식에 대한 수요 증가는 다양한 전임상 연구 응용 분야에서 시장을 확대시키고 있습니다. 종양학, 신경학, 순환기학, 면역학 연구에서 소동물 이미징의 사용 증가는 종단적, 정량적, 번역적 이미징 솔루션에 대한 수요와 결합하여 시장 성장의 새로운 기회를 창출하고 있습니다. 또한, 연구기관, 제약사, 이미징 솔루션 제공업체 간의 협력 관계 증가와 혁신적인 이미징 기술 연구 및 개발에 대한 투자 증가는 시장 확대를 더욱 촉진하고 있습니다.

조사 대상 기업 사례(42개사)

• Aspect Imaging Ltd.
• Berthold Technologies GmbH & Co.
• Bruker Corp.
• LI-COR Biosciences, Inc.
• Mediso Ltd.
• MILabs B.V.
• Miltenyi Biotec GmbH
• New England Biolabs, Inc.
• Northridge Tri-Modality Imaging, Inc.
• PerkinElmer, Inc.
• Scanco Medical AG
• Sofie Biosciences, Inc.
• Thermo Fisher Scientific Inc.
• Uvp.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 기타 지역

제4장 경쟁

영문목차

Global Small Animal Imaging (In-Vivo) Market to Reach US$4.8 Billion by 2030

The global market for Small Animal Imaging (In-Vivo) estimated at US$2.9 Billion in the year 2023, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Micro-Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Optical Imaging segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$793.7 Million While China is Forecast to Grow at 7.0% CAGR

The Small Animal Imaging (In-Vivo) market in the U.S. is estimated at US$793.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$735.2 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Small Animal Imaging (In-Vivo) Market - Key Trends and Drivers Summarized

Why Is Small Animal Imaging Essential for Preclinical Studies?

Small animal imaging (in-vivo) is crucial for preclinical studies as it provides non-invasive, high-resolution imaging solutions for monitoring biological processes in live animals. This technology is extensively used in drug development, cancer research, cardiovascular studies, and neuroscience to assess disease progression, therapeutic efficacy, and pharmacokinetics. Small animal imaging techniques, such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Computed Tomography (CT), offer real-time, longitudinal, and quantitative data, enhancing the reliability and translational value of preclinical research. The increasing focus on personalized medicine, targeted therapies, and molecular imaging is driving the adoption of small animal imaging systems across research institutions, pharmaceutical companies, and academic laboratories.

How Are Technological Advancements Enhancing Small Animal Imaging?

Technological advancements are enhancing small animal imaging by integrating multi-modal, hybrid, and AI-driven imaging systems that provide comprehensive insights into biological processes. The development of multi-modal imaging systems combining MRI, PET, SPECT, and CT modalities is enabling researchers to capture multiple data points simultaneously, improving the accuracy and depth of preclinical studies. Innovations in AI-based image analysis, deep learning algorithms, and data management systems are facilitating automated, high-throughput, and quantitative analysis of imaging data, reducing the time and complexity of preclinical workflows. Furthermore, the emergence of portable, compact, and user-friendly imaging systems is expanding the accessibility of advanced imaging technologies to small and mid-sized research labs, enhancing collaboration and knowledge sharing.

Which Market Segments Are Leading the Adoption of Small Animal Imaging?

Imaging modalities include micro-MRI, PET, SPECT, CT, optical imaging (bioluminescence and fluorescence), and ultrasound, with optical imaging and PET leading the market due to their high sensitivity, specificity, and real-time imaging capabilities. Use case encompass oncology, neurology, cardiology, infectious diseases, and immunology, with oncology being the largest segment due to the high prevalence of cancer research and drug development studies. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations (CROs), with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for small animal imaging due to advanced research infrastructure, while Asia-Pacific is emerging as a high-growth region driven by increasing investments in life sciences, expanding R&D activities, and growing focus on precision medicine.

What Are the Key Drivers of Growth in the Small Animal Imaging Market?

The growth in the small animal imaging market is driven by several factors, including the rising demand for preclinical research and drug development, increasing adoption of multi-modal, hybrid, and AI-driven imaging systems, and advancements in non-invasive, high-resolution imaging technologies. The development of compact, portable, and user-friendly imaging systems is driving market adoption among academic and research institutions, pharmaceutical companies, and CROs. The growing demand for high-sensitivity, high-specificity, and real-time imaging modalities is expanding the market reach among diverse preclinical research applications. The increasing use of small animal imaging in oncology, neurology, cardiology, and immunology research, coupled with the demand for longitudinal, quantitative, and translational imaging solutions, is creating new opportunities for market growth. Additionally, the rising collaborations between research institutes, pharmaceutical companies, and imaging solution providers and the increasing investments in R&D for innovative imaging technologies are further supporting market expansion.

Select Competitors (Total 42 Featured) -

• Aspect Imaging Ltd.
• Berthold Technologies GmbH & Co. KG
• Bruker Corp.
• LI-COR Biosciences, Inc.
• Mediso Ltd.
• MILabs B.V.
• Miltenyi Biotec GmbH
• New England Biolabs, Inc.
• Northridge Tri-Modality Imaging, Inc.
• PerkinElmer, Inc.
• Scanco Medical AG
• Sofie Biosciences, Inc.
• Thermo Fisher Scientific Inc.
• Uvp. LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Small Animal Imaging (In-Vivo) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advancements in Non-Invasive, High-Resolution Imaging Technologies Propel Market Innovation
  • Increasing Focus on Personalized Medicine and Molecular Imaging Expands Addressable Market Opportunity
  • Integration of Multi-Modal Imaging Systems (MRI, PET, SPECT, CT) Reinforces Market Competitiveness
  • Rising Investments in Oncology, Neurology, and Cardiovascular Research Spurs Market Adoption
  • Focus on Enhancing Imaging Sensitivity, Specificity, and Quantitative Analysis Drives Market Demand
  • Emergence of AI-Driven Image Analysis and Deep Learning Algorithms in Small Animal Imaging Accelerates Market Transformation
  • Growing Use of Fluorescence, Bioluminescence, and Ultrasound Imaging in In-Vivo Studies Sustains Market Growth
  • Development of Compact, User-Friendly, and High-Throughput Imaging Systems Expands Market Reach
  • Rising Preference for Longitudinal, Real-Time, and 4D Imaging Modalities Generates New Growth Opportunities
  • Growing Application of Small Animal Imaging in Infectious Diseases, Immunology, and Regenerative Medicine Spurs Market Expansion
  • Shift Towards Hybrid Imaging Platforms, Portable Solutions, and Remote Data Analysis Supports Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Small Animal Imaging (In-Vivo) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Micro-magnetic resonance imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Optical imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Nuclear imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Monitoring treatment response by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Bio-distribution of drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cancer cell detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Longitudinal studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• JAPAN
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• CHINA
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• EUROPE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• FRANCE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 68: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: France Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 71: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: France Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• GERMANY
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 74: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Germany Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 77: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Germany Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 80: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Italy Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 83: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Italy Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 86: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: UK Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 89: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: UK Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Rest of World Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Rest of World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Rest of World Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: Rest of World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

IV. COMPETITION